NCBI » Bookshelf » Medical Microbiology » Virology » Parvoviruses
 
mmed
Medical Microbiology
4th
BaronSamuel
University of Texas Medical Branch at Galveston, Galveston, Texas
University of Texas Medical Branch at Galveston0-9631172-1-11996
infectious diseasesmicrobiology

 Chapter 64:  Parvoviruses

John R. Pattison and Gary Patou
A3395
General Concepts

Clinical Manifestations

Individuals with erythema infectiosum have a fever and a rubelliform rash that begins on the face and spreads to the trunk and limbs. In patients with a preexisting hemolytic anemia (e.g., sickle cell anemia), the disease can cause aplastic crisis (transient bone marrow erythroid aplasia). In women, disease late in pregnancy can cause spontaneous abortion and edematous anemic stillbirth (hydrops fetalis).

Structure

Parvoviruses are non-enveloped, icosahedral particles 18 to 26 nm in diameter. Plus and minus DNA strands are packaged into separate virions in approximately equal proportion. There are two capsid proteins.

Classification and Antigenic Types

Parvoviruses are classified by size, morphology, and genomic organization. A single antigenic type is associated with human disease.

Multiplication

Replication takes place in the nucleus of dividing cells. The single-stranded DNA genome forms an intermediate double-stranded form, which replicates to form progeny-positive and -negative single-stranded DNA. Positive and negative strands are packaged separately in viral capsids in equal numbers.

Pathogenesis

The disease is transmitted by the respiratory route. The virus replicates in committed erythroid precursor cells in the bone marrow, leading to erythroid aplasia. Aplastic anemia develops in patients with underlying hemolytic anemia, and rash and arthralgia develop at the time specific antibody appears.

Host Defenses

Specific IgM and IgG antibodies develop in response to infection.

Epidemiology

Erythema infectiosum is found worldwide. Outbreaks occur predominantly in spring, mainly in school children and young adults, with peaks of activity at 4- to 5-year intervals.

Diagnosis

Diagnosis is by detecting viral DNA in serum and a rise in parvovirus-specific IgM or IgG.

Control

No specific antiviral therapy or vaccine is yet available.

Contents

Introduction

Clinical Manifestations

Structure

Classification and Antigenic Types

Multiplication

Pathogenesis

Host Defenses

Epidemiology

Diagnosis

Control

References

Help ǀ Contact Bookshelf
Medical Microbiology1996
(navigation arrows) Go to previous chapter Go to next chapter Go to top of this page Go to bottom of this page Go to Table of Contents